February 2, 2009 - Cardiac Dimensions Inc. today said it received the CE Mark approval for its CARILLON Mitral Contour System from KEMA Quality B.V., a European Union Notified Body from the Netherlands.
February 2, 2009 - CardiArc, Inc., along with Clinical Engineering Consultants Inc. (CEC) of Erlanger, KY, today said CEC will provide field service for the CardiArc HD-SPECT system.
CEC also brings technical consultation with CardiArc on the field service manual. In addition CEC will sell the CardiArc system in the Ohio River Valley area.
February 3, 2009 - The FDA has granted Pathway Medical Technologies Inc., 510(k) clearance to market its newest peripheral atherectomy catheter, the Jetstream G2, for use in the treatment of peripheral artery disease (PAD) in the lower limbs.
February 3, 2009 - Cerenis Therapeutics SA, a privately held pharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, has in-licensed intellectual property supporting an investigational new treatment of aortic valve stenosis (AVS) based on HDL therapy.
February 3, 2009 – Barco closed the divestment operation of its Advanced Visualization (AVIS) activities to Toshiba Medical Systems Corp., Tokyo, Japan, in a move by Barco to focus on its medical display systems business.
February 2, 2009 - A recent study published in Clinical Cardiology revealed that "emerging risk factors," including detailed cholesterol measurements such as HDL(2) and remnant lipoprotein particles, play a much greater role in determining heart disease risk than previously thought, and that traditional risk factors such as age, standard cholesterol levels and blood pressure do a poor job of predi
February 2, 2009 - An online survey of 1,888 physicians, medical group executives and staff, released today by Allscripts, concludes that U.S. physician groups are eager to accept a proposed multi-billion dollar package of government loans, grants and incentives designed to promote broader adoption of information technologies such as the electronic health record (EHR).
February 2, 2009 - A new multi-center study of 39,821 newborns published in the January 2009 issue of the British Medical Journal (BMJ) found that the addition of Masimo SET pulse oximetry screening before discharge increased detection of congenital heart disease (CHD) by 28 percent from 72 percent to 92 percent when compared to a cohort group of 108,604 newborns in whom no pulse oximetry screenin
February 2, 2009 - Cook Medical’s new Advance PTX drug-eluting balloon was used in a live case transmitted from The Heart Center Leipzig/Park Hospital in Leipzig, Germany, at last week’s ISET 2009 International Symposium on Endovascular Therapy.